col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Cytokine
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―18 Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis Laura Bergantini, Miriana d'Alessandro, Paolo Cameli, Ambra Otranto, Simona Luzzi, Francesco Bianchi, Elena Bargagli
2 [GO] 2021―Dec―25 Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients S. Ashrafzadeh-Kian, M.R. Campbell, J.C. Jara Aguirre, J. Walsh, A. Kumanovics, G. Jenkinson, et al. (+3)
3 [GO] 2021―Dec―14 Effect of SARS-CoV-2 seropositivity on antigen - specific cytokine and chemokine responses in latent tuberculosis Anuradha Rajamanickam, Nathella Pavan Kumar, Padmapriyadarsini Chandrasekaran, Arul Nancy, P.K. Bhavani, Nandhini Selvaraj, et al. (+7)
4 [GO] 2021―Nov―06 In-vitro cytokine production and nasopharyngeal microbiota composition in the early stage of COVID-19 infection Mehmet Hursitoglu, Nilgun Isıksacan, Betul Erismis, Faruk Karandere, Alev Kural, A.Baki Kumbasar, Kadriye Kart Yasar
5 [GO] 2021―Nov―06 Association and predictive value of biomarkers with severe outcomes in hospitalized patients with sars-cov-2 infection Rafael Fernandez-Botran, Stephen Furmanek, Raghava Sekhar Ambadapoodi, Evelyn Expósito González, Meredith Cahill, Ruth Carrico, et al. (+2)
6 [GO] 2021―Oct―29 Corrigendum to “Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients” [Cytokine 148 (2021) 155662] Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vasilios M. Polymeropoulos, Bushra A. Mina, Christos M. Polymeropoulos, Mihael H. Polymeropoulos
7 [GO] 2021―Oct―06 Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: a prospective observational study Elena Sancho Ferrando, Katja Hanslin, Michael Hultström, Anders Larsson, Robert Frithiof, Miklos Lipcsey
8 [GO] 2021―Oct―06 IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? Chia Siang Kow, Abdullah Faiz Zaihan, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
9 [GO] 2021―Sep―27 Randomized trial drug controlled compendious transcriptome analysis supporting broad and phase specific therapeutic potential of multiple candidates in COVID-19 Abhay Sharma
10 [GO] 2021―Sep―09 Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19) Aeshah A. Ahmed, Ali H. Ad'hiah
11 [GO] 2021―Sep―03 SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3 Wenwen Zhang, Zhenling Ma, Yaru Wu, Xixi Shi, Yanyan Zhang, Min Zhang, et al. (+3)
12 [GO] 2021―Aug―06 COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us? Claudio G. Gallo, Sirio Fiorino, Giovanni Posabella, Donato Antonacci, Antonio Tropeano, Emanuele Pausini, et al. (+9)
13 [GO] 2021―Jul―29 Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’ Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vasilios Polymeropoulos, Christos Polymeropoulos, Mihael H. Polymeropoulos
14 [GO] 2021―Jul―03 Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study Sergey N. Avdeev, Natalia V. Trushenko, Natalia A. Tsareva, Andrey I. Yaroshetskiy, Zamira M. Merzhoeva, Galia S. Nuralieva, et al. (+5)
15 [GO] 2021―Jul―03 Clinical Applications of Thrombopoietin Silencing: A Possible Therapeutic Role in COVID-19? Vincent J. Alentado, Alison R. Moliterno, Edward F. Srour, Melissa A. Kacena
16 [GO] 2021―Jul―03 Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease Nataša Todorović-Raković, Jonathan R. Whitfield
17 [GO] 2021―Jun―07 Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19 Takehiro Hasegawa, Atsushi Nakagawa, Kohjin Suzuki, Kazuto Yamashita, Saya Yamashita, Niina Iwanaga, et al. (+3)
18 [GO] 2021―May―26 The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Gerwyn Morris, Chiara C Bortolasci, Basant K Puri, Wolfgang Marx, Adrienne O'Neil, Eugene Athan, et al. (+5)
19 [GO] 2021―May―24 Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients A. Gradin, H. Andersson, T. Luther, S. Bülow Anderberg, S. Rubertsson, M. Lipcsey, et al. (+4)
20 [GO] 2021―Apr―19 Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19 Jie Geng, Feng Wang, Zhiwei Huang, Xiaobo Chen, Yuliang Wang
21 [GO] 2021―Apr―19 Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico Azalia Avila-Nava, Arturo Cortes-Telles, Darwin Torres- Erazo, Stephanie López-Romero, Rodolfo Chim Aké, Ana Ligia Gutiérrez Solis
22 [GO] 2021―Apr―01 Aberrant Cytokine Expression in COVID-19 Patients: Associations between Cytokines and Disease Severity Yueting Tang, Jiayu Sun, Huaqin Pan, Fen Yao, Yumeng Yuan, Mi Zeng, et al. (+12)
23 [GO] 2021―Mar―27 IL-6 and IL-10 are associated with disease severity and a higher comorbidity in adults with COVID-19 Rafael Luís Luporini, Joice M. de A. Rodolpho, Lauro Tatsuo Kubota, Ana Carolina Baptista Moreno Martin, Marcia R. Cominetti, Fernanda de Freitas Anibal, Henrique Pott-Junior
24 [GO] 2021―Mar―26 Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019 Hao Chen, Rundong Qin, Zhifeng Huang, Wenting Luo, Peiyan Zheng, Huimin Huang, et al. (+3)
25 [GO] 2021―Mar―20 Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019 Guo-Lin Wang, Hui-Xia Gao, Yu-Ling Wang, Xiao Wei, Yu-Zhen Liu, Jian-Hua Lu, et al. (+10)
26 [GO] 2021―Mar―14 Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication Pruthvi Gowda, Shruti Patrick, Shanker Datt Joshi, Rajesh Kumar Kumawat, Ellora Sen
27 [GO] 2021―Mar―07 The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19 Kristina Schönfelder, Katharina Breuckmann, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, et al. (+8)
28 [GO] 2021―Feb―23 Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: a review Benjamin M. Liu, Thomas B Martins, Lisa K. Peterson, Harry R. Hill
29 [GO] 2021―Feb―03 “The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction” Luca Giovanni Locatello, Chiara Bruno, Giandomenico Maggiore, Maria Cilona, Pietro Orlando, Giuseppe Fancello, et al. (+5)
30 [GO] 2021―Jan―28 Prognostic bioindicators in severe COVID-19 patients L. Bergantini, E. Bargagli, M. d'Alessandro, R.M. Refini, P. Cameli, L. Galasso, et al. (+9)
31 [GO] 2021―Jan―18 Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? Ramin Sami, Farshid Fathi, Nahid Eskandari, Meysam Ahmadi, Reza ArefNezhad, Hossein Motedayyen
32 [GO] 2021―Jan―18 Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19 Wafa Sayah, Ismahane Berkane, Imène Guermache, Mohamed Sabri, Fatma Zahra Lakhal, Sarah Yasmine Rahali, et al. (+19)
33 [GO] 2021―Jan―18 The Impact of COVID-19 Infection On The Cytokine Profile of Pregnant Women: A Prospective Case-Control Study Atakan Tanacan, Nuray Yazihan, Seyit Ahmet Erol, Ali Taner Anuk, Fatma Didem Yucel Yetiskin, Derya Biriken, et al. (+4)
34 [GO] 2021―Jan―18 Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia Luca Quartuccio, Martina Fabris, Arianna Sonaglia, Maddalena Peghin, Rossana Domenis, Adriana Cifé, et al. (+2)
35 [GO] 2021―Jan―18 ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? Carolina Scagnolari, Camilla Bitossi, Agnese Viscido, Federica Frasca, Giuseppe Oliveto, Mirko Scordio, et al. (+8)
36 [GO] 2020―Dec―16 Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients Sara Bülow Anderberg, Tomas Luther, Malin Berglund, Rolf Larsson, Sten Rubertsson, Miklos Lipcsey, et al. (+3)
37 [GO] 2020―Dec―15 Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19 Allen Widysanto, Andree Kurniawan, Nata Pratama Hardjo Lugito, Mira Yuniarti, Catherine Gunawan, Jessica Wiryanto, Tasya Meidy Pradhana
38 [GO] 2020―Dec―11 Cytokine Storm Induced by SARS-CoV-2 Infection: The Spectrum of its Neurological Manifestations Parisorn Thepmankorn, John Bach, Ahmed Lasfar, Xilin Zhao, Sami Souayah, Zhao Zhong Chong, Nizar Souayah
39 [GO] 2020―Dec―09 A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19 Lelia Wagner, Walter E. Haefeli, Uta Merle, Hanns-Martin Lorenz, Nicolas Hohmann, Johanna Weiss, Dirk Theile
40 [GO] 2020―Nov―09 An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis Yili Liu, Daihong Chen, Junjie Hou, Haicong Li, Dan Cao, Mingquan Guo, et al. (+5)
41 [GO] 2020―Oct―23 The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19 Juan Gómez, Guillermo M. Albaiceta, Elías Cuesta-Llavona, Marta García-Clemente, Carlos López-Larrea, Laura Amado-Rodríguez, et al. (+9)
42 [GO] 2020―Oct―12 Probable Positive Effects of the Photobiomodulation as an Adjunctive Treatment in COVID-19: A Systematic Review Marzieh Nejatifard, Sohrab Asefi, Raika Jamali, Michael R. Hamblin, Reza Fekrazad
43 [GO] 2020―Sep―30 Cytokine Profile and Disease Severity in Patients with COVID-19 Ali Ghazavi, Ali Ganji, Nafiseh Keshavarzian, Somayeh Rabiemajd, Ghasem Mosayebi
44 [GO] 2020―Sep―29 Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19 Hasan Satış, Hasan Selçuk Özger, Pınar Aysert Yıldız, Kenan Hızel, Özlem Gulbahar, Gonca Erbaş, et al. (+5)
45 [GO] 2020―Aug―20 ADE and hyperinflammation in SARS-CoV2 infection- Comparison with dengue hemorrhagic fever and feline infectious peritonitis Maryse Cloutier, Madhuparna Nandi, Awais Ullah Ihsan, Hugues Allard Chamard, Subburaj Ilangumaran, Sheela Ramanathan
46 [GO] 2020―Aug―15 A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases Abdullah Mahmud-Al-Rafat, Md. Muzammal Haque Asim, Andrew W. Taylor-Robinson, Apurba Majumder, Abdul Muktadir, Hasneen Muktadir, et al. (+4)
47 [GO] 2020―May―30 COVID-19 cytokine storm: The anger of inflammation Mehdi Mahmudpour, Jamshid Roozbeh, Mohsen Keshavarz, Shokrollah Farrokhi, Iraj Nabipour
48 [GO] 2020―May―21 Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions Rezvan Noroozi, Wojciech Branicki, Krzysztof Pyrc, Paweł P. Łabaj, Ewelina Pospiech, Mohammad Taheri, Soudeh Ghafouri-Fard


[de][en]

Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.016 sec